FDA Drug Shortage Database
Clonazepam (Klonopin) shortage
The FDA Drug Shortage Database lists 1 of 40 clonazepam presentations as limited or unavailable (updated October 3, 2026); the first entry was posted on March 10, 2023. 39 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule IV
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 1mg tablet | 1 | 13 | 0 |
| 2mg tablet | 0 | 12 | 0 |
| 5mg tablet | 0 | 14 | 0 |
Which presentations are listed?
Limited or unavailable now (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated August 17, 2026 | Limited Availability; Other |
Listed now, available (39)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated October 1, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated October 1, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 59651-722-01) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 59651-722-99) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-00) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-01) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-05) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-30) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated October 1, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 59651-723-01) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 59651-723-99) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-00) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-01) | Rubicon Research Private Limited | Current posted March 27, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-05) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-30) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated October 1, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Teva Pharmaceuticals USA, Inc. | Current posted March 10, 2023, updated October 1, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Accord Healthcare Inc. | Current posted March 10, 2023, updated October 3, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Prinston Pharmaceutical, Inc. | Current posted March 10, 2023, updated September 2, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 59651-724-01) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 59651-724-05) | Aurobindo Pharma USA | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-01) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-05) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-30) | Rubicon Research Private Limited | Current posted March 10, 2023, updated June 1, 2026 | Available |
| Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Cheplapharm Arzneimittel GmbH | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Cheplapharm Arzneimittel GmbH | Current posted March 10, 2023, updated October 2, 2026 | Available |
| Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Cheplapharm Arzneimittel GmbH | Current posted March 10, 2023, updated September 16, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Alprazolam | Anxiety | No current entry | 30 labelers | $0.0236 per tablet 0.25 mg tablet |
| Lorazepam | Anxiety | In shortage | 36 labelers | $0.0344 per tablet 0.5 mg tablet |
| Diazepam | Anxiety | No current entry | 45 labelers | $0.0283 per tablet 10 mg tablet |
| Chlordiazepoxide | Anxiety | No current entry | 15 labelers | $0.158 per capsule 25 mg capsule |
| Clorazepate | Anxiety, Seizures and epilepsy | No current entry | 8 labelers | $0.524 per tablet 3.75 mg tablet |
| Oxazepam | Anxiety | No current entry | 6 labelers | $0.725 per capsule 10 mg capsule |
| Amitriptyline and chlordiazepoxide | Anxiety | No current entry | 1 labeler | $1.20 per unit 5-12.5 |
| Topiramate | Seizures and epilepsy | No current entry | 47 labelers | $0.0567 per tablet 100 mg tablet |
| Lamotrigine | Seizures and epilepsy | A presentation being discontinued | 49 labelers | $0.0268 per tablet 25 mg tablet |
| Levetiracetam | Seizures and epilepsy | No current entry | 84 labelers | $0.0736 per tablet 500 mg tablet |
| Phenobarbital | Seizures and epilepsy | A presentation being discontinued | none listed | $0.213 per tablet 100 mg tablet |
| Lacosamide | Seizures and epilepsy | No current entry | 57 labelers | $0.174 per tablet 100 mg tablet |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage